CombiMatrix Corp (NASDAQ:CBMX)

1.96
Delayed Data
As of 2:08pm ET
 -0.10 / -4.85%
Today’s Change
1.09
Today|||52-Week Range
3.65
+51.94%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Electronic Components
MARKET CAP
$22.8M

Company Description

CombiMatrix Corp. is a molecular diagnostics company, which operates primarily in the field of genetic analysis and molecular diagnostics through its wholly-owned subsidiary, CombiMatrix Diagnostics. It provides DNA-based clinical diagnostic testing services to physicians, hospitals, clinics and other laboratories in the areas of pre-and postnatal development disorders and hematology/oncology genomics. CombiMatrix was founded in October 1995 and is headquartered in Irvine, CA.

Contact Information

CombiMatrix Corp.
310 Goddard
Irvine California 92618
P:(949) 753-0624
Investor Relations:

Employees

Shareholders

Individual stakeholders5.94%
Other institutional11.69%
Mutual fund holders1.79%

Top Executives

Mark D. McDonoughPresident, Chief Executive Officer & Director
Scott R. BurellCFO, Secretary, Treasurer & Head-Media Relations
Trilochan SahooVP-Clinical Affairs & Cytogenetics Director
Hisashi Sho FujiVice President-Engineering & Production
Karine HovanesVP-Scientific Advancement & Laboratory Director

To view my watchlist

Not a member yet?

Sign up now for a free account